An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

The past few months have been rather gloomy in the health research space in Kenya. It all started with withdrawal of the USAID funding, bringing to a halt some ongoing research programmes in the ...

U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV ...

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 cause of hospitalization in infants.

Severity of lung injury with respiratory syncytial virus (RSV) infection is variable and may be related to genetic variations. This preliminary report describes a prospective, family-based ...

Five years removed from the onset of Covid-19's global sweep, research into another subset of the coronavirus has scientists ...

A rare cell in the lining of lungs is fundamental to the organ-wide response necessary to repair damage from toxins like ...

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...

"Scientists warn of bat virus just one mutation from infecting humans." ScienceDaily. ScienceDaily, 12 June 2025. <www.sciencedaily.com / releases / 2025 / 06 / 250612081312.htm>.

The VRC has been a key contributor to what Frieden calls “a real golden age of vaccines” in the past couple decades. Particular successes in recent memory include immunizations for Ebola and ...

Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory infections for which effective treatment options remain limited. Herein, we employed a computational structure-based ...